Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Molecular Partners AG - American Depositary Shares (NQ:MOLN)

3.800 +0.030 (+0.80%)
Streaming Delayed Price Updated: 9:30 AM EDT, Apr 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 625
Open 3.810
Bid (Size) 3.610 (13)
Ask (Size) 3.860 (1)
Prev. Close 3.770
Today's Range 3.800 - 3.810
52wk Range 3.510 - 12.70
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Molecular Partners Announces all Board Proposals Approved at Annual General Meeting
From Molecular Partners
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga

Performance

YTD
-22.0%
-22.0%
1 Month
-2.6%
-2.6%
3 Month
-28.3%
-28.3%
6 Month
-44.0%
-44.0%
1 Year
-2.1%
-2.1%

More News

Read More
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Molecular Partners to hold three poster presentations at AACR 2025
From Molecular Partners
Via GlobeNewswire
Molecular Partners Publishes Invitation to Annual General Meeting 2025
From Molecular Partners
Via GlobeNewswire
Molecular Partners Reports Highlights from Q4 2024 and Key Financials for Full Year 2024
From Molecular Partners
Via GlobeNewswire
Molecular Partners Announces Participation at Upcoming Investor Conferences and 2024 Financial Results Conference Call
From Molecular Partners
Via GlobeNewswire
Molecular Partners and Orano Med expand partnership to develop Targeted Alpha Radio-Therapies for cancer
From Molecular Partners
Via GlobeNewswire
Earnings Scheduled For March 6, 2025
Via Benzinga
Molecular Partners Outlines Clinical Expansion Plans and Strengthens Radiopharma Strategic Focus for 2025 at 43rd Annual J.P. Morgan Healthcare Conference
From Molecular Partners
Via GlobeNewswire
Molecular Partners to Present at JP Morgan Healthcare Conference and Baader Helvea Swiss Equities Conference in January
From Molecular Partners
Via GlobeNewswire
Molecular Partners Presents Clinical Data Supporting its Ongoing MP0533 Study and Preclinical Data on Next-Gen Conditioning Agent MP0621 at ASH 2024
From Molecular Partners
Via GlobeNewswire
Molecular Partners Presents Preclinical Proof-of-Concept for CD3 Switch-DARPin T Cell Engager, Clinical Biomarker Analyses for MP0317 at SITC 2024
From Molecular Partners
Via GlobeNewswire
Molecular Partners Announces Upcoming Poster Presentations at the 65th ASH Annual Meeting and Exposition
From Molecular Partners
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Molecular Partners Q3 2024 Interim Management Statement: Multiple Updates Across Portfolio, Radio-DARPin candidate MP0712 preparing for clinical entry, MP0533 Phase 1 on-going
From Molecular Partners
Via GlobeNewswire
Molecular Partners Announces Pricing of $20 Million Underwritten Offering
From Molecular Partners
Via GlobeNewswire
Molecular Partners and Orano Med Present Additional Positive Preclinical Data Supporting DLL3 Targeting Radio-DARPin Therapeutic Candidate MP0712 at EANM 2024
From Molecular Partners
Via GlobeNewswire
Molecular Partners and Orano Med Strengthen Agreement to Co-Develop 212Pb-Based Radio-DARPin Therapeutics
From Molecular Partners
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Molecular Partners Announces upcoming poster presentations at the 2024 SITC Annual Meeting
From Molecular Partners
Via GlobeNewswire
Molecular Partners Announces Upcoming Top-Rated Oral Presentation on MP0712, a ²¹²Pb-labeled Radio-DARPin Therapeutic targeting DLL3 for Small Cell Lung Cancer co-developed with Orano Med, at EANM 2024
From Molecular Partners
Via GlobeNewswire
Molecular Partners Reports H1 2024 Corporate Highlights and Financials
From Molecular Partners
Via GlobeNewswire

Frequently Asked Questions

Is Molecular Partners AG - American Depositary Shares publicly traded?
Yes, Molecular Partners AG - American Depositary Shares is publicly traded.
What exchange does Molecular Partners AG - American Depositary Shares trade on?
Molecular Partners AG - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Molecular Partners AG - American Depositary Shares?
The ticker symbol for Molecular Partners AG - American Depositary Shares is MOLN on the Nasdaq Stock Market
What is the current price of Molecular Partners AG - American Depositary Shares?
The current price of Molecular Partners AG - American Depositary Shares is 3.800
When was Molecular Partners AG - American Depositary Shares last traded?
The last trade of Molecular Partners AG - American Depositary Shares was at 04/22/25 09:30 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.